Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...

German startup Pieris hopes they could prove a cheaper alternative to antibodies. (Click here for company profile.) The structure of lipocalins was first elucidated during the early 1980s ...

Comparatively, Pieris Pharmaceuticals has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. 70.5% of Notable Labs shares are owned by institutional investors.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

David Pieris Renewable Energy (Private) Limited (DPRE) successfully completed yet another major solar energy project at the Manufacturing Complex of David Pieris Motor Company (Lanka) Limited (DPMCL) ...

David Pieris Automobiles (Private) Limited (DPA) successfully delivered the first set of BAIC X55 II SUVs to its customers recently at the BAIC Showroom in Battaramulla. Rohana Dissanayake, Group ...

David Pieris Group of Companies Group Chairman and Managing Director Rohana Dissanayake presents the key and documents to one of the first set of customers Rohan Fernando David Pieris Automobiles ...